Related Experiment Video
Updated: May 26, 2025

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Stress-Induced Hyperglycemia Predicts Poor Outcomes in Primary Intracerebral Hemorrhage Patients
Kevin Gilotra1, Jade Basem1, Melissa Janssen2
1Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USA.
Insights
Stress-induced hyperglycemia (SIH) in non-diabetic patients with intracerebral hemorrhage (ICH) predicts worse outcomes than diabetes-related hyperglycemia. SIH is a stronger predictor of poor outcomes in ICH patients.
Area of Science:
- Neurology
- Endocrinology
- Critical Care Medicine
Background:
- Hyperglycemia is linked to poor outcomes in intracerebral hemorrhage (ICH).
- Stress-induced hyperglycemia (SIH) occurs in non-diabetic patients, distinct from chronic hyperglycemia in diabetes mellitus (DM).
- The differential impact of SIH versus DM-related hyperglycemia on ICH outcomes requires investigation.
Purpose of the Study:
- To investigate the influence of hyperglycemia on primary ICH patient outcomes.
- To compare outcomes between patients with SIH and those with DM-related hyperglycemia.
- To identify hyperglycemia as a predictor of outcomes in ICH.
Main Methods:
- Retrospective analysis of 636 primary ICH patients (January 2011-December 2022).
- Data collected: admission glucose, pre-existing DM, inpatient mortality, modified Rankin Scale (mRS) scores.
- Regression models compared outcomes between hyperglycemic/diabetic patients and normoglycemic/non-diabetic controls.
Main Results:
- SIH patients exhibited significantly higher inpatient mortality and worse mRS scores (p < 0.001).
- Hyperglycemia secondary to DM was also associated with higher mortality and worse mRS scores.
- The association between SIH and poor outcomes was stronger than that for DM-related hyperglycemia.
Conclusions:
- SIH appears to be a more significant predictor of poor outcomes in ICH patients than chronic hyperglycemia from DM.
- Further prospective studies are needed to understand the impact of dynamic glucose changes on ICH outcomes.
- This research highlights the importance of managing acute hyperglycemia in ICH.
Introduction:
The current literature suggests hyperglycemia can predict poor outcomes in patients with primary intracerebral hemorrhage (ICH). Chronic hyperglycemia is seen in patients with pre-existing diabetes (DM); however, acute hyperglycemia in non-diabetic patients is defined as stress-induced hyperglycemia (SIH). This study explored the influence of hyperglycemia on outcomes of primary ICH patients both in the presence and absence of pre-existing DM.
Methods:
Data regarding admission glucose, pre-existing DM, inpatient mortality, and modified Rankin Scale (mRS) scores at discharge were available for 636 patients admitted to Stony Brook Hospital from January 2011 to December 2022 with a primary diagnosis of ICH. Regression models were used to compare outcomes between patients with admission hyperglycemia and/or pre-existing DM to a control group of normoglycemic and non-diabetic ICH patients.
Results:
Patients with SIH had higher inpatient mortality rates and worse mRS scores at discharge (p < 0.001). An association with higher mortality and worse mRS scores at discharge was also seen in patients with hyperglycemia secondary to DM, although the strength of this association was weaker when compared to patients with SIH.
Conclusions:
Our findings suggest that SIH may play a greater role in predicting poor outcomes at discharge rather than a history of poorly controlled DM with chronic hyperglycemia. To develop a more thorough understanding of this topic, prospective studies evaluating the effect of changes in serum glucose during hospital stay on short and long-term outcomes is needed.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

